Controlled clinical trial of a novel hemostatic agent in cardiac surgery
- 31 May 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 69 (5), 1376-1382
- https://doi.org/10.1016/s0003-4975(00)01194-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Modulation of an Acquired Coagulation Factor V Inhibitor with Intravenous Immune GlobulinJournal of Pediatric Hematology/Oncology, 1997
- Aprotinin improves outcome of single-ventricle palliationThe Annals of Thoracic Surgery, 1996
- Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrestThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Blood transfusion costs: a multicenter studyTransfusion, 1991
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Shock, Transfusion, and PneumonectomyAnnals of Surgery, 1990
- Evaluation of hemostatic agents in experimental splenic lacerationsThe American Journal of Surgery, 1983
- Pulmonary microvascular response to hemorrhagic shock, resuscitation, and recoveryJournal of Applied Physiology, 1979
- The hemostatic mechanism after open-heart surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1975
- EFFECTS OF VARIOUS HEMOSTYPTIC DRUGS IN RATSPlastic and Reconstructive Surgery, 1972